This improvement saw earnings per share increase to 2.89 Australian cents for the period, up from 2.42 Australian cents in 3QFY2022.

However, revenue for 3QFY2023 slipped slightly to A$187.8 million, down by 2.7% compared to last year.

Still, Civmec’s net profit margin was able to improve by 1.5% points to 7.8%.

Amid strong tendering activity across all sectors, Civmec says it continues to focus on securing projects that will generate good returns, optimise workforce utilisation and maintain a strong, high quality order book.

This continued focus has enabled the group to increase earnings and margins during the quarter, despite a slight decrease in revenue.

<span class='see_also_inread'><b>See also: <a class='gtm_see_also_1_inread' style='text-decoration: underline;' href='/capital/brokers-calls/rhb-upbeat-raffles-medicals-contract-win-providing-medical-services?utm_source=website&utm_medium=article&utm_campaign=ONPAGESEO'>RHB ‘upbeat’ on Raffles Medical’s contract win for providing medical services at Connect@Changi</a></b></span>

CEO Patrick Tallon says: “Our continued disciplined approach to contract selection and execution coupled with our relentless focus on cost containment, optimising productivity and working with our clients proactively along the project life cycle in these times of high inflation and tight labour markets has allowed us to generate yet another set of strong results for our shareholders.”

Shares in Civmec closed flat at 70.5 Australian cents on May 10.

Civmec continues growth momentum with 3QFY2023 earnings of A$14.6 mil

VTAC proposes business combination with live streaming platform 17LIVE

Data is the new oil but is it as dirty?

'Transition credits' could sweeten deal for early retirement of coal-fired power plants: MAS, McKinsey paper

DPM Lawrence Wong appointed as GIC’s deputy chairman

Will the Rising Sun keep rising?

Trade Stocks, ETFs, Forex and Futures with Phillip Nova:

RHB ‘upbeat’ on Raffles Medical’s contract win for providing medical services at Connect@Changi

Redevelopment of Marina Square ‘decent RNAV accretion’ of 4% to 6% for UOL, says Citi

Citi ups TP while DBS keeps 'buy' call on Singtel following long-awaited divestment of loss-making Trustwave

Civmec continues growth momentum with 3QFY2023 earnings of A$14.6 mil

Related News

Highlights

VTAC proposes business combination with live streaming platform 17LIVE

Related News

LHN Group reports strong occupancy rates for key projects in 3QFY2023; sees steady growth for rest of 2HFY2023

Analysts remain positive on LREIT’s portfolio after improving retail operations in 3QFY2023 update

Banks to drive market rebound through April, as March Fed meeting outcome looms large for local stocks: DBS